Search results
Results From The WOW.Com Content Network
Sodium glycerophosphate, sold under the brand name Glycophos, is a medication used to supplement phosphate. [3] [4] It is administered via intravenous infusion. [3] [4] Sodium glycerophosphate is an organic phosphate salt. [3] [4] It was approved for medical use in Australia in November 2019. [5] [3] [6]
It is diagnosed based on a blood phosphate concentration of less than 0.81 mmol/L (2.5 mg/dL). [1] When levels are below 0.32 mmol/L (1.0 mg/dL) it is deemed to be severe. [2] Treatment depends on the underlying cause. [1] Phosphate may be given by mouth or by injection into a vein. [1]
This template's initial visibility currently defaults to autocollapse, meaning that if there is another collapsible item on the page (a navbox, sidebar, or table with the collapsible attribute), it is hidden apart from its title bar; if not, it is fully visible. To change this template's initial visibility, the |state= parameter may be used:
Likewise, tripolyphosphoric acid H 5 P 3 O 10 yields at least five anions [H 5−k P 3 O 10] k−, where k ranges from 1 to 5, including tripolyphosphate [P 3 O 10] 5−. Tetrapolyphosphoric acid H 6 P 4 O 13 yields at least six anions, including tetrapolyphosphate [P 4 O 13] 6−, and so on. Note that each extra phosphoric unit adds one extra ...
The following is an archived discussion of the DYK nomination of the article below. Please do not modify this page. Subsequent comments should be made on the appropriate discussion page (such as this nomination's talk page, the article's talk page or Wikipedia talk:Did you know), unless there is consensus to re-open the discussion at this page.
Phosphogypsum is a by-product from the production of phosphoric acid by treating phosphate ore with sulfuric acid according to the following reaction: Ca 5 (PO 4) 3 X + 5 H 2 SO 4 + 10 H 2 O → 3 H 3 PO 4 + 5 (CaSO 4 · 2 H 2 O) + HX where X may include OH, F, Cl, or Br
The PRISMA flow diagram, depicting the flow of information through the different phases of a systematic review. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is an evidence-based minimum set of items aimed at helping scientific authors to report a wide array of systematic reviews and meta-analyses, primarily used to assess the benefits and harms of a health care ...
8074 64654 Ensembl ENSG00000118972 ENSMUSG00000000182 UniProt Q9GZV9 Q9EPC2 RefSeq (mRNA) NM_020638 NM_022657 RefSeq (protein) NP_065689 NP_073148 Location (UCSC) Chr 12: 4.37 – 4.38 Mb Chr 6: 127.05 – 127.06 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Fibroblast growth factor 23 (FGF-23) is a protein and member of the fibroblast growth factor (FGF) family which participates ...